kabutan

CREATE MEDIC CO.,LTD., January-September (Third Quarter Cumulative) Ordinary Profit Decreases by 16%, July-September Ordinary Profit Decreases by 29%

Thu Oct 31, 2024 3:00 pm JST Earnings

5187 CREATE MEDIC CO.,LTD. 【J-GAAP】

Earnings Report

CREATE MEDIC CO.,LTD. <5187> [TSE-S] announced its financial results after the market closed on October 31st (15:00). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending December 2024 (January to September) decreased by 16.3% from the same period last year to 545 million yen. The progress rate against the 900 million yen full-year plan was 60.6%, also falling below the five-year average of 74.4%.

Based on the third-quarter cumulative performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to December period (4Q) is expected to expand by 60.6% from the same period last year, reaching 355 million yen.

In the most recent three-month period, from July to September (3Q), the consolidated ordinary profit decreased to 200 million yen, a 28.6% decrease compared to the same period last year. The operating profit margin worsened from 8.8% in the same period last year to 7.2%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2022 9,047 621 755 483 53.2 90.5 Oct 31, 2022 J-GAAP
Jan - Sep, 2023 9,168 612 651 9 1.1 74.7 Oct 31, 2023 J-GAAP
Jan - Sep, 2024 9,512 521 545 744 83.9 60.6 Oct 31, 2024 J-GAAP
YoY +3.8% -14.9% -16.3% +8,166.7% +7,810.4%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2023 6,560 468 501 -162 -17.8 20 Feb 14, 2024 J-GAAP
Jul - Dec, 2024 Guidance 6,732 577 555 417 48.6 20 Aug 5, 2024 J-GAAP
YoY +2.6% +23.3% +10.8% － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 12,326 741 834 482 53.0 37 Feb 13, 2023 J-GAAP
Dec, 2023 12,585 803 872 154 16.9 37 Feb 14, 2024 J-GAAP
Dec, 2024 Guidance 13,032 868 900 967 112.6 39 Feb 14, 2024 J-GAAP
YoY +3.6% +8.1% +3.2% +527.9% +565.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 3,143 277 280 -307 -36.2 8.8 Oct 31, 2023 J-GAAP
Oct - Dec, 2023 3,417 191 221 145 15.9 5.6 Feb 14, 2024 J-GAAP
Jan - Mar, 2024 2,976 98 106 59 6.5 3.3 May 7, 2024 J-GAAP
Apr - Jun, 2024 3,324 193 239 491 54.8 5.8 Aug 5, 2024 J-GAAP
Jul - Sep, 2024 3,212 230 200 194 21.9 7.2 Oct 31, 2024 J-GAAP
YoY +2.2% -17.0% -28.6% － －

Related Articles